Pharmaceuticals News and Research

RSS

EDC announces USD 67.5 M in financing for Valeant Pharmaceuticals

Export Development Canada today announced a previously disbursed USD 67.5 M in financing for Montreal's Valeant Pharmaceuticals International, Inc., Canada's largest multinational pharmaceutical company.

27 May 2015

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

AbbVie presented new results from the Phase 3 GIFT-I study of its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan.

27 May 2015

People who have higher HDL function experience fewer heart attacks later in life

HDL is the 'good cholesterol' that helps remove fat from artery walls, reversing the process that leads to heart disease. Yet recent drug trials and genetic studies suggest that simply pushing HDL levels higher doesn't necessarily reduce the risk of heart disease.

27 May 2015

ETH Zurich researchers develop new measurement technique to improve NanoMRI imaging

NanoMRI is a scanning technique that produces nondestructive, high-resolution 3-D images of nanoscale objects, and it promises to become a powerful tool for researchers and companies exploring the shape and function of biological materials such as viruses and cells in much the same way as clinical MRI today enables investigation of whole tissues in the human body.

27 May 2015

HUYA Bioscience International named winner of bronze Stevie Award

HUYA Bioscience International has been named the winner of a bronze Stevie Award in the Health Products & Services and Pharmaceuticals category in the second annual Asia-Pacific Stevie Awards.

26 May 2015

Mast Therapeutics initiates Phase 3 extension study of vepoloxamer in sickle cell disease

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, heart failure, and arterial disease, today reported that it has initiated an open-label, multicenter Phase 3 extension study of vepoloxamer (MST-188) in sickle cell disease, referred to as "EPIC-E."

26 May 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

22 May 2015

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.

22 May 2015

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Merus Labs International Inc. is pleased to announce that one of its wholly owned subsidiaries has signed a definitive agreement to acquire the rights to manufacture, market, and sell two established specialty pharmaceutical products in certain European and other markets.

22 May 2015

GHIT Fund expands investments in leishmaniasis, diagnostic tests

The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million.

22 May 2015

UH pharmacy students receive awards for excellence in clinical skills, disease management

University of Houston pharmacy students wrapped up the spring semester with awards for excellence in professional service, clinical skills and disease management, earning kudos at the state level from the Texas Society of Health-System Pharmacists.

22 May 2015

Canada lagging behind similar OECD countries with regard to public drug plan reimbursement

Canadians face wait times of over 460 days in order to get access to new, potentially lifesaving medicines in public drug plans, according to a new IMS Brogan report commissioned by Rx&D. Overall, the report ranks Canada 16 out of 18 similar OECD countries.

21 May 2015

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..

From Magstim 21 May 2015

Banook Group consolidates three subsidiaries under one unique name and brand

Banook Group, an international provider of cardiac safety, central imaging and endpoint adjudication services, today announces that its three subsidiaries will now be combined into one unique name and brand.

21 May 2015

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes.

21 May 2015

Turkey steadily emerges as one of hottest healthcare markets in the world

Driven by reforms and private investments, Turkey is steadily emerging as one of the hottest healthcare markets in the global arena. The country has doubled its healthcare spending in the last 10 years, reaching $62.3 billion, with its large population of 74.7 million and an increasing patient base.

21 May 2015

SARIL-RA-TARGET trial: Sarilumab meets co-primary efficacy endpoints in RA patients

Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.

21 May 2015

Australian survey reveals that most people never been told about risk of overdiagnosis

A national survey reveals that only one in ten Australians report being told about the risk of overdiagnosis by their doctors, according to research published today in the scientific journal PLOS ONE.

21 May 2015

FDA gives marketing clearance for new device that helps doctors to accurately assess children's weight

The Emmes Corporation today announced that the U.S. Food and Drug Administration has given marketing clearance for a new device that allows doctors to more accurately assess children's weight without the use of a weight scale. Weight estimates are used in emergency situations and in developing countries where scales may not be available.

20 May 2015

In-house training solutions from PTI: save time and cost in upskilling staff

With course topics that include, but aren’t limited to, business strategy, clinical trials, manufacturing, R&D and regulatory affairs, PTI covers all aspects of the drug and device development lifecycle...

From Pharmaceutical Training International 20 May 2015

Pharmaceuticals News and Research

EDC announces USD 67.5 M in financing for Valeant Pharmaceuticals

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

People who have higher HDL function experience fewer heart attacks later in life

ETH Zurich researchers develop new measurement technique to improve NanoMRI imaging

HUYA Bioscience International named winner of bronze Stevie Award

Mast Therapeutics initiates Phase 3 extension study of vepoloxamer in sickle cell disease

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

GHIT Fund expands investments in leishmaniasis, diagnostic tests

UH pharmacy students receive awards for excellence in clinical skills, disease management

Canada lagging behind similar OECD countries with regard to public drug plan reimbursement

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Banook Group consolidates three subsidiaries under one unique name and brand

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Turkey steadily emerges as one of hottest healthcare markets in the world

SARIL-RA-TARGET trial: Sarilumab meets co-primary efficacy endpoints in RA patients

Australian survey reveals that most people never been told about risk of overdiagnosis

FDA gives marketing clearance for new device that helps doctors to accurately assess children's weight

In-house training solutions from PTI: save time and cost in upskilling staff

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring